Phase I study of Multiple-Vaccine Therapy in Patient with Refractory Non-Small-Cell Lung Cancer to Chemotherapy.
Phase 1
- Conditions
- on-Small-Cell Lung Cancer
- Registration Number
- JPRN-UMIN000002141
- Lead Sponsor
- Department of Respiratory Medicine, Juntendo University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 9
Inclusion Criteria
Not provided
Exclusion Criteria
1.Pregnancy 2.Breastfeeding 3.Concurrent treatment with steroids or immunosuppressing agent 4.No other malignancy requiring treatment 5.No curative traumatic wound 6.Decision of unsuitableness by principal investigator or physician-in-charge
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation of safety and adverse effects of vaccination therapy and determination of the recommended dose for phase II trial
- Secondary Outcome Measures
Name Time Method